These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 30894497)
1. Development of highly potent glucocorticoids for steroid-resistant severe asthma. He Y; Shi J; Nguyen QT; You E; Liu H; Ren X; Wu Z; Li J; Qiu W; Khoo SK; Yang T; Yi W; Sun F; Xi Z; Huang X; Melcher K; Min B; Xu HE Proc Natl Acad Sci U S A; 2019 Apr; 116(14):6932-6937. PubMed ID: 30894497 [TBL] [Abstract][Full Text] [Related]
2. Discovery of a highly potent glucocorticoid for asthma treatment. He Y; Shi J; Yi W; Ren X; Gao X; Li J; Wu N; Weaver K; Xie Q; Khoo SK; Yang T; Huang X; Melcher K; Xu HE Cell Discov; 2015; 1():15035-. PubMed ID: 27066265 [TBL] [Abstract][Full Text] [Related]
3. Concomitant administration of nitric oxide and glucocorticoids improves protection against bronchoconstriction in a murine model of asthma. Jonasson S; Hedenstierna G; Hjoberg J J Appl Physiol (1985); 2010 Aug; 109(2):521-31. PubMed ID: 20538845 [TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid resistant asthma: T-lymphocyte steroid metabolism and sensitivity to glucocorticoids and immunosuppressive agents. Corrigan CJ; Bungre JK; Assoufi B; Cooper AE; Seddon H; Kay AB Eur Respir J; 1996 Oct; 9(10):2077-86. PubMed ID: 8902470 [TBL] [Abstract][Full Text] [Related]
6. Anti- trachea inflammatory effects of diosgenin from Dioscorea nipponica through interactions with glucocorticoid receptor α. Junchao Y; Zhen W; Yuan W; Liying X; Libin J; Yuanhong Z; Wei Z; Ruilin C; Lu Z J Int Med Res; 2017 Feb; 45(1):101-113. PubMed ID: 27913746 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological properties of the enhanced-affinity glucocorticoid fluticasone furoate in vitro and in an in vivo model of respiratory inflammatory disease. Salter M; Biggadike K; Matthews JL; West MR; Haase MV; Farrow SN; Uings IJ; Gray DW Am J Physiol Lung Cell Mol Physiol; 2007 Sep; 293(3):L660-7. PubMed ID: 17575011 [TBL] [Abstract][Full Text] [Related]
8. Functional proteomics for the characterization of impaired cellular responses to glucocorticoids in asthma. Pazdrak K; Kurosky A Adv Exp Med Biol; 2014; 795():255-70. PubMed ID: 24162914 [TBL] [Abstract][Full Text] [Related]
10. The N363S and I559N single nucleotide polymorphisms of the h-GR/NR3C1 gene in patients with bronchial asthma. Panek M; Pietras T; Antczak A; Fabijan A; Przemęcka M; Górski P; Kuna P; Szemraj J Int J Mol Med; 2012 Jul; 30(1):142-50. PubMed ID: 22469783 [TBL] [Abstract][Full Text] [Related]
11. Nuclear translocation of the glucocorticoid receptor in fibroblasts of asthmatic patients with nasal polyposis insensitive to glucocorticoid treatment. Embid C; Fernández-Bertolín L; Pujols L; Alobid I; Mullol J; Picado C Arch Bronconeumol; 2011 Mar; 47(3):115-21. PubMed ID: 21288619 [TBL] [Abstract][Full Text] [Related]
12. Linoleic acid metabolite leads to steroid resistant asthma features partially through NF-κB. Panda L; Gheware A; Rehman R; Yadav MK; Jayaraj BS; Madhunapantula SV; Mahesh PA; Ghosh B; Agrawal A; Mabalirajan U Sci Rep; 2017 Aug; 7(1):9565. PubMed ID: 28851976 [TBL] [Abstract][Full Text] [Related]
13. Airway Epithelial Cells Are Crucial Targets of Glucocorticoids in a Mouse Model of Allergic Asthma. Klaßen C; Karabinskaya A; Dejager L; Vettorazzi S; Van Moorleghem J; Lühder F; Meijsing SH; Tuckermann JP; Bohnenberger H; Libert C; Reichardt HM J Immunol; 2017 Jul; 199(1):48-61. PubMed ID: 28515280 [TBL] [Abstract][Full Text] [Related]
14. Update on glucocorticoid action and resistance. Ito K; Chung KF; Adcock IM J Allergy Clin Immunol; 2006 Mar; 117(3):522-43. PubMed ID: 16522450 [TBL] [Abstract][Full Text] [Related]
15. Neutralizing TNFα restores glucocorticoid sensitivity in a mouse model of neutrophilic airway inflammation. Dejager L; Dendoncker K; Eggermont M; Souffriau J; Van Hauwermeiren F; Willart M; Van Wonterghem E; Naessens T; Ballegeer M; Vandevyver S; Hammad H; Lambrecht B; De Bosscher K; Grooten J; Libert C Mucosal Immunol; 2015 Nov; 8(6):1212-25. PubMed ID: 25760421 [TBL] [Abstract][Full Text] [Related]
16. Advances with glucocorticoids in the treatment of asthma: state of the art. Ora J; Calzetta L; Matera MG; Cazzola M; Rogliani P Expert Opin Pharmacother; 2020 Dec; 21(18):2305-2316. PubMed ID: 32808828 [TBL] [Abstract][Full Text] [Related]
17. Fluticasone propionate results in improved glucocorticoid receptor binding affinity and reduced oral glucocorticoid requirements in severe asthma. Nimmagadda SR; Spahn JD; Nelson HS; Jenkins J; Szefler SJ; Leung DY Ann Allergy Asthma Immunol; 1998 Jul; 81(1):35-40. PubMed ID: 9690571 [TBL] [Abstract][Full Text] [Related]